Tagged with CCE

government Ana Ríus became the Secretary of Health of Puerto Rico in 2013 following a very dynamic career as Head of the Puerto Rico Health Medical Services Administration. She discusses the current changes being made in the country’s health system and how Medicare Advantage funding is critical to maintaining a stable…

insurance Jim O’Drobinak came to Puerto Rico at the end of 2011, following a career largely based in Florida, to run Medical Card System (MCS), a major insurance provider on the island. He shares his experiences and challenges to ensure a functioning health system in a time of doubt regarding healthcare…

Merck Merck’s managing director for South Africa and general manager for Southeast Africa reveals why the company takes a long-term perspective when investing in African countries, helping to shape healthcare systems, working on CSR initiatives and public/private partnerships by partnering with governments, how the way of doing business on the continent…

Pharmacy José Pérez de Gracia, president of Farmacias Plaza, discusses the environment between multinational chains and local pharmacies as well as his own plan for extended growth throughout Puerto Rico in the future. A couple of multinational pharmacy chains could be said to control a large monopoly of the market share…

consultancy Daneris Fernández, CEO and president of DGF Consulting Group, outlines the firm’s services that help Latin American companies enter Puerto Rico as well as its focus on hospital consulting. What was the inspiration for your change of direction from Merck to DGF? My last position in Merck was as vice…

IMS IMS Health recently released its World Review 2015. The new general manager of North Latin America shares the company’s assessment on the performance of the Mexican pharmaceutical market for 2014, what trends are shaping the industry as well as the moderate, yet positive outlook for 2015. How would you assess…

association The industry of medical devices is still not very well understood. Pablo Dávila shared with us his overview on the Mexican market, how the Mexican Association of Innovative Medical Device Industries (AMID) is interested on putting the sector on the map. Could you please tell us a bit more about…

MSD The managing director of MSD in Mexico explains why the Mexican pharmaceutical market is an attractive market in which to compete, but not one that will deliver 12 to 15 percent growth year on year, why 2014 has been a tough year for the sector and how MSD is focusing…

Janssen The country manager of one of the foremost providers of sustainable and integrated healthcare solutions describes the sorts of local adaptations that need to be enacted when launching a product on the Romanian market. He also speaks extensively about the state of the local medical device market and its likely future potential. Can…

Lilly A recent arrival from China, Lilly’s Turkey MD Daniel Lucas assesses the country’s healthcare system and raises key questions about the sustainability of the system at large going forward, and the authorities’ approach to reform. You came to Turkey in October after more than four years in China. What is your…

MSD MSD Turkey has benefited in recent years from the ability to engage in local business development initiatives, and managing director Hatice Demiray has prioritized initiatives such as reducing internal bureaucracy and incentivizing CRM use to improve operational efficiencies. You took over last year as managing director of MSD Turkey, after…

GSK GSK’s VP and Area GM Pharmaceuticals, Turkey and Caucasus, and chairman of Turkey’s innovative pharmaceutical association, discusses the effectiveness of the government’s current strategy for reducing the trade deficit in the pharmaceutical industry, and the need for the industry and government to approach all discussions with a partnership mentality. Do…